![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, July 05, 2021 1:01:45 PM
There has been frequent mention of comparing the failure of Prurisol to Brilacidin. All the results of P was released by IPIX with effectively no independent verification as the trials continued. B has had third party verification multiple times. The RBL's have shown the remarkable efficacy of B. So much so that GMU will submit their research soon. It's inconceivable that a heralded research institute would present research of a failure.
I served in the Medical Corps of the US Army and the Military Health System Research Symposium is a monumental feather in ipix's cap. Their potential affirmation of the multiple uses for B is and could be epic. The monetary benefits from them could possibly dwarf how much IPIX could make from B and covid alone. Their awards through the D O D could be astronomical for profits. I have seen that first hand. The uses of B for military troops world wide is mind boggling as all the armed forces stockpile drugs in the Billions of dollars.
Also, a Machine Learning (Artificial Intelligence) model used to screen 1,482 compounds ranked Brilacidin in the top three percent of compounds predicted to be the most effective against SARS-CoV-2, the virus responsible for COVID-19. Published in Bioinformatics, by Oxford University Press, the Machine Learning ranking is based on a compound’s predicted ability, due to its physicochemical properties, to bind to coronavirus proteins and thus inhibit viral replication.
And there are so many more verifiable testing and positive results from 3rd party independent venues that I won't repeat it to spare being duplicative. Let's not forget that the FDA awarded a fast track for B in covid testing. Was their thinking to expose B as a failure sooner? I think not.
Boards are meant to decimate different points of view both positive and negative. So please stop decimating B has failed in the clinical trials. NO ONE KNOWS (period)! Not Leo, not FDA, not RBL's, Not Putin and Not Biden and not at the clinical sights either. The trials have not been unblinded as of this date. But it seems you indicate that you have received privileged information of B's failure could you please submit your source for all us shareholders. My DD has found no such data.
I'll address Putin/Russia et al on next post.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM